Sunshine Act Meeting, 4612 [06-866]

Download as PDF 4612 Federal Register / Vol. 71, No. 18 / Friday, January 27, 2006 / Notices investigation on the basis of two settlement agreements. rmajette on PROD1PC67 with NOTICES FOR FURTHER INFORMATION CONTACT: Steven Crabb, Esq., Office of the General Counsel, U.S. International Trade Commission, 500 E Street, SW., Washington, DC 20436, telephone (202) 708–5432. Copies of non-confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street, SW., Washington, DC 20436, telephone (202) 205–2000. General information concerning the Commission may also be obtained by accessing its Internet server (http://www.usitc.gov). The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at http:// edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: This investigation was instituted by the Commission based on a complaint filed by BenQ Corporation of Taiwan and BenQ America Corporation of Irvine, California. See 70 FR 35453 (June 20, 2005). The complaint alleged violations of section 337 of the Tariff Act of 1930 in the importation into the United States, the sale for importation, and the sale in the United States after importation of certain DVD/CD players and recorders, color television receivers and monitors, and components thereof by reason of infringement of claims 7– 11 and 13–15 of U.S. Patent No. 5,270,821, and claims 1, 2, 4, and 5 of U.S. Patent No. 6,683,842. The complaint named Thomson Inc. of Indianapolis, Indiana as the respondent. On December 9, 2005, the private parties filed a joint motion to terminate the investigation on the basis of two settlement agreements. On December 14, 2005, the Commission investigative attorney filed a response in support of the parties’ joint motion to terminate the investigation. On December 21, 2005, the ALJ issued an ID (Order No. 16) granting the joint motion to terminate the investigation on the basis of the settlement agreements. The ALJ found no indication that such termination of the investigation would adversely impact the public interest. No party filed a petition to review the subject ID. The Commission has determined not to review the ALJ’s ID. Accordingly, the above-referenced investigation is hereby terminated. VerDate Aug<31>2005 15:17 Jan 26, 2006 Jkt 208001 The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in sections 210.21(b), and 210.42 of the Commission’s Rules of Practice and Procedure (19 CFR 210.21, 210.42). By order of the Commission. Issued: January 23, 2006. Marilyn R. Abbott, Secretary to the Commission. [FR Doc. E6–1038 Filed 1–26–06; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION to issuing a regulation under 21 U.S.C. 952(a)(2)(B) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing. Therefore, in accordance with 21 CFR 1301.34(a), this is notice that on August 17, 2005, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78664, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in Schedule I and II: Drug Schedule [USITC SE–06–009] Sunshine Act Meeting United States International Trade Commission. TIME AND DATE: February 8, 2006 at 11 a.m. PLACE: Room 101, 500 E Street, SW., Washington, DC 20436, Telephone: (202) 205–2000. STATUS: Open to the public. MATTERS TO BE CONSIDERED: 1. Agenda for future meetings: none. 2. Minutes. 3. Ratification List. 4. Inv. No. 731–TA–1089 (Final)(Certain Orange Juice from Brazil)—briefing and vote. (The Commission is currently scheduled to transmit its determination and Commissioners’ opinions to the Secretary of Commerce on or before February 21, 2006.) 5. Outstanding action jackets: None. In accordance with Commission policy, subject matter listed above, not disposed of at the scheduled meeting, may be carried over to the agenda of the following meeting. AGENCY HOLDING THE MEETING: Issued: January 25, 2006. By order of the Commission. Marilyn R. Abbott, Secretary to the Commission. [FR Doc. 06–866 Filed 1–25–06; 3:48 pm] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in Schedule I or II and prior PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 Cathinone (1235) .......................... Methcathinone (1237) .................. N-Ethylamphetamine (1475) ........ Gamma hydroxybutyric acid (2010). Ibogaine (7260) ............................ Tetrahydrocannabinols (7370) ..... Mescaline (7381) .......................... 4-Bromo-2,5dimethoxyamphetamine (7391). 4-Bromo-2,5dimethoxyphenethylamine (7392). 4-Methyl-2,5dimethoxyamphetamine (7395). 2,5-Dimethoxyamphetamine (7396). 3,4-Methylenedioxyamphetamine (7400). 3,4Methylenedioxymethamphetamine (7404). 3,4Methylenedioxymethamphetamine (7405). 4-Methoxyamphetamine (7411) ... Psilocybin (7437) .......................... Psilocyn (7438) ............................. Etorphine (9056) ........................... Heroin (9200) ............................... Pholcodine (9314) ........................ Amphetamine (1100) .................... Methamphetamine (1105) ............ Methylphenidate (1724) ................ Amobarbital (2125) ....................... Pentobarbital (2270) ..................... Cocaine (9041) ............................. Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Benzoylecgonine (9180) ............... Ethylmorphine (9190) ................... Meperidine (9230) ........................ Methadone (9250) ........................ Dextropropoxyphene, bulk (nondosage forms) (9273). Morphine (9300) ........................... Thebaine (9333) ........................... Levo-alphacetylmethadol (9648) .. Oxymorphone (9652) ................... I I I I I I I I I I I I I I I I I I I I II II II II II II II II II II II II II II II II II II II The company plans to import small quantities of the listed controlled E:\FR\FM\27JAN1.SGM 27JAN1

Agencies

[Federal Register Volume 71, Number 18 (Friday, January 27, 2006)]
[Notices]
[Page 4612]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-866]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[USITC SE-06-009]


Sunshine Act Meeting

Agency Holding the Meeting: United States International Trade 
Commission.

Time and Date: February 8, 2006 at 11 a.m.

Place: Room 101, 500 E Street, SW., Washington, DC 20436, Telephone: 
(202) 205-2000.

Status: Open to the public.

Matters To Be Considered: 
1. Agenda for future meetings: none.
2. Minutes.
3. Ratification List.
4. Inv. No. 731-TA-1089 (Final)(Certain Orange Juice from Brazil)--
briefing and vote. (The Commission is currently scheduled to transmit 
its determination and Commissioners' opinions to the Secretary of 
Commerce on or before February 21, 2006.)
5. Outstanding action jackets: None.
    In accordance with Commission policy, subject matter listed above, 
not disposed of at the scheduled meeting, may be carried over to the 
agenda of the following meeting.

    Issued: January 25, 2006.

    By order of the Commission.

Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 06-866 Filed 1-25-06; 3:48 pm]
BILLING CODE 7020-02-P